Yes, all antimicrobial end-use registrations must be supported by efficacy data. However, not all data is required to be submitted to the EPA. Not sure what data requirements are needed to satisfy your antimicrobial product registration? TSG’s team of experts can help you navigate product performance guidelines and support your company with any test method interpretation, implementation, and validation needs.

Yes! Generating efficacy data can be expensive. It’s best to have guidance on the appropriate requirements before initiating product development. Proper planning can save your company time and money. Additionally, novel antimicrobial claims are difficult to substantiate. Such products may require a creative efficacy strategy. Get in touch at [email protected] to find out how we can support you.

Generally, no. However, California does require efficacy data be submitted for review for any products making antimicrobial claims.

There are many overlapping data requirements between Canada and the US, but there are also some slight differences. For example, nonpublic health claims still require GLP efficacy data in Canada, unlike the US. Planning for these differences can expedite registration in both countries.